结核性支气管胸膜瘘的诊疗进展

doi:10.19983/j.issn.2096-8493.20260027

结核与肺部疾病杂志 ›› 2026, Vol. 7 ›› Issue (3): 398-403.doi: 10.19983/j.issn.2096-8493.20260027

结核性支气管胸膜瘘的诊疗进展

虞桂平¹^,², 王天宇², 卢志猛², 宋言峥¹()

¹ 上海市公共卫生临床中心胸外科, 上海 201500
² 南通大学附属江阴医院胸心外科, 江阴 214400

收稿日期:2026-02-13 出版日期:2026-06-20 发布日期:2026-06-12
通信作者: 宋言峥 E-mail:yanzhengsong@163.com
基金资助:
江阴市卫生健康委员会科研项目青年项目(Q202410);江苏大学医教协同创新基金(JDYY2023152);南通大学教学改革研究课题(2024I13);南通大学临床医学专项科研基金(2024LQ039);2025年度徐州医科大学高等教育教改研究课题(XYJG010)

Advances in the diagnosis and treatment of tuberculous bronchopleural fistula

Yu Guiping¹^,², Wang Tianyu², Lu Zhimeng², Song Yanzheng¹()

¹ Department of Thoracic Surgery, Shanghai Public Health Clinical Center (Fudan University), Shanghai 201500, China
² Department of Thoracic and Cardiovascular Surgery, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin 214400, China

Received:2026-02-13 Online:2026-06-20 Published:2026-06-12
Contact: Song Yanzheng E-mail:yanzhengsong@163.com
Supported by:
Jiangyin Municipal Health Commission Scientific Research Project Youth Project(Q202410);Jiangsu University Medical and Education Collaborative Innovation Fund Project(JDYY2023152);Research Project on Teaching Reform, Nantong University(2024I13);Special Research Fund for Clinical Medicine, Nantong University(2024LQ039);2025 Xuzhou Medical University Higher Education Reform Research Project(XYJG010)

摘要/Abstract

摘要：

结核性支气管胸膜瘘(bronchopleural fistula, BPF)是结核病变引发的一种严重并发症,它的发生与结核病的病情发展、治疗效果,以及患者自身的免疫状况息息相关。由于结核性BPF常合并严重感染且治疗周期长、难度大,给临床治疗带来严重挑战。近年来,随着影像学技术、介入医学及材料科学的飞速发展,结核性BPF的诊疗策略正经历深刻变革,笔者通过介绍结核性BPF的流行病学及临床特征,进一步探讨其诊疗进展,为临床决策提供系统参考。

关键词: 结核, 胸膜, 支气管瘘, 诊断, 治疗学

Abstract:

Tuberculous bronchopleural fistula (BPF) is a severe complication arising from tuberculosis. Its occurrence is closely related to the progression of tuberculosis, treatment efficacy, and the patient’s own immune status. Due to the frequent coexistence of severe infections and the lengthy and challenging treatment period, BPF poses significant challenges to clinical treatment. In recent years, with the rapid development of imaging technology, interventional medicine, and material science, the diagnostic and treatment strategies for BPF are undergoing profound changes. This article introduces the epidemiology and clinical characteristics of BPF, further explores its diagnostic and treatment progress, and provides a systematic reference for clinical decision-making.

Key words: Tuberculosis, pleural, Bronchial fistula, Diagnosis, Therapeutics

中图分类号:

虞桂平, 王天宇, 卢志猛, 宋言峥. 结核性支气管胸膜瘘的诊疗进展[J]. 结核与肺部疾病杂志, 2026, 7(3): 398-403. doi: 10.19983/j.issn.2096-8493.20260027

Yu Guiping, Wang Tianyu, Lu Zhimeng, Song Yanzheng. Advances in the diagnosis and treatment of tuberculous bronchopleural fistula[J]. Journal of Tuberculosis and Lung Disease, 2026, 7(3): 398-403. doi: 10.19983/j.issn.2096-8493.20260027

参考文献 36

[1]	董斌然, 齐威. 289例活动性肺结核患者密切接触者感染情况及影响因素分析. 结核与肺部疾病杂志, 2026, 7(2): 171-178. doi:10.19983/j.issn.2096-8493.20250167.
[2]	Stewart AGA, Boyd SC. Tuberculous bronchopleural fistula. Respirol Case Rep, 2021, 9(4): e00740. doi:10.1002/rcr2.740.
[3]	Bathobakae L, Shahid A, Wilkinson T, et al. Tuberculous Bronchopleural Fistula: A Rare and Life-Threatening Disease. J Investig Med High Impact Case Rep, 2023, 11: 23247096231220466. doi:10.1177/23247096231220466.
[4]	Giller DB, Giller BM, Giller BD, et al. Risk factors for bronchopleural complications after pneumonectomy. Khirurgiia (Mosk), 2025(3): 7-15. doi:10.17116/hirurgia20250317. pmid: 40103240
[5]	Bazongo M, Togo S, Ouattara MA, et al. Indications and results of pulmonary resections in a developing country. Rev Mal Respir, 2021, 38(3): 225-230. doi:10.1016/j.rmr.2020.11.004. pmid: 33341327
[6]	Majeed FA, Raza A, Imtiaz T, et al. Pediculated Intercostal Muscle Flaps in Bronchiactasis Resectional Surgery for Bronchial Stump Reinforcement. J Coll Physicians Surg Pak, 2020, 30(2): 197-200. doi:10.29271/jcpsp.2020.02.197. pmid: 32036830
[7]	Yanti B, Hadi S, Harrika F, et al. Giant bronchopleural fistula and empyema in a tuberculosis patient with diabetes mellitus: Vista from a high tuberculosis burden country in Southeast Asia. Narra J, 2022, 2(2): e81. doi:10.52225/narra.v2i2.81. pmid: 38449704
[8]	Alves D, Corga da Silva R, Morais Passos R, et al. Bronchopleural Fistula in Tuberculosis: A Challenge to Mechanical Ventilation. Cureus, 2025, 17(1): e76756. doi:10.7759/cureus.76756.
[9]	Singh M, Vaid M. A Case Report of Spontaneous Subcutaneous Emphysema Secondary to Pulmonary Tuberculosis. Cureus, 2025, 17(4):e82353. doi:10.7759/cureus.82353.
[10]	Choudhuri B, Chakraborty M, Biswas P. A Unique Case of Candida auris Infection Presenting With Hydropneumothorax and Bronchopleural Fistula: A Diagnostic and Therapeutic Challenge. Cureus, 2024, 16(11): e73147. doi:10.7759/cureus.73147.
[11]	Osaki M, Kobayashi T, Yoshida S, et al. Mycobacterium avium Pleurisy with Bronchopleural Fistula Resulting in Rapidly Progressive Respiratory Failure Diagnosed by Transbronchial Autopsy. Intern Med, 2023, 62(8): 1237-1241. doi:10.2169/internalmedicine.9749-22.
[12]	Nasreen S, Ali N, Ahmad T, et al. Effect of Circumference of Open Window Thoracostomy on Chest Wall Closure, Pleural Cavity Clearance, and Lung Expansion. Cureus, 2021, 13(10): e18781. doi:10.7759/cureus.18781.
[13]	Wen P, Wang X, Liu Y, et al. Clinicopathological outcome in 27 children with tuberculous empyema in Shandong Provincial Chest Hospital, Jinan, China. Paediatr Int Child Health, 2022, 42(3-4): 133-136. doi:10.1080/20469047.2023.2214497.
[14]	Bai Y, Chi J, Wang H, et al. Case report: Endobronchial closure of postoperative bronchopleural fistula with embolization coil: a sandwich-like approach. Front Med (Lausanne), 2024, 11: 1333157. doi:10.3389/fmed.2024.1333157.
[15]	Santos AP, Rodrigues RS, Aarntzen EHJG, et al. 18F-fluorodeoxyglucose PET/CT scans for thoracic tuberculosis: current evidence and future perspectives. Eur Respir Rev, 2025, 34(176): 240289. doi:10.1183/16000617.0289-2024.
[16]	金普乐, 葛晖, 彭乱顺, 等. 亚甲蓝盐水定位气胸与支气管瘘相关支气管的临床研究. 中华结核和呼吸杂志, 2014, 37(11): 831-834. doi:10.3760/cma.j.issn.1001-0939.2014.11.009.
[17]	Kim S, Eom JS, Mok J. Bronchoscopic Strategies to Improve Diagnostic Yield in Pulmonary Tuberculosis Patients. Tuberc Respir Dis (Seoul), 2024, 87(3): 302-308. doi:10.4046/trd.2024.0020.
[18]	Riyanto SB, Marhana IA, Hasan H. Medical Thoracoscopy in Diagnosis and Management of Silicotuberculosis with Pneumothorax: A Report of a Rare Case. Am J Case Rep, 2025, 26: e946204. doi:10.12659/AJCR.946204.
[19]	蒋钰辉, 刘奇斌, 姚利, 等. 单孔胸腔镜手术在结核性毁损肺治疗中的应用. 中华外科杂志, 2024, 62(5): 432-437. doi:10.3760/cma.j.cn112139-20230706-00259.
[20]	Massud A, Syed Sulaiman SA, Ahmad N, et al. Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study. Front Pharmacol, 2022, 13: 883483. doi:10.3389/fphar.2022.883483.
[21]	Kalita J, Pandey PC, Shukla R, et al. Predictors of fever response in tuberculous meningitis: A clinical, MRI and biomarker study. Eur J Clin Invest, 2022, 52(2): e13701. doi:10.1111/eci.13701.
[22]	Keren M, Aynaci A, Bulut I, et al. Severe cutaneous adverse drug reactions due to antituberculosis drugs and their management. North Clin Istanb, 2025, 12(6): 661-666. doi:10.14744/nci.2025.92593.
[23]	Wang X, Yang J, Zhang J, et al. Polypharmacy driven synergistic toxicities in elderly breast cancer chemotherapy drug management and adverse drug reactions: a mini review. Front Pharmacol, 2025, 16: 1654353. doi:10.3389/fphar.2025.1654353.
[24]	Ismail MZ, Hadi F, Wan Ahmed WA. Multiple Tuberculous Bronchopleural Fistulas Complicated by Hydropneumothorax: A Case Report of Successful Conservative Management. Cureus, 2025, 17(11): e98205. doi:10.7759/cureus.98205.
[25]	Petreanu CA, Constantin T, Iosifescu R, et al. Necrotizing fasciitis of the chest wall: A clinical case report and literature review. Exp Ther Med, 2022, 23(1): 90. doi:10.3892/etm.2021.11013. pmid: 34934455
[26]	Plaksin SA, Farshatova LI. Intraoperative pleurodesis with talc and trichloroacetic acid for exudative pleuritis. Khirurgiia (Mosk), 2021(1): 22-26. doi:10.17116/hirurgia202101122. pmid: 33395508
[27]	Hayashi D, Kojima K, Okishio K, et al. A Case of Negative Pressure Wound Therapy Following Open Window Thoracostomy With Muscle Flap Filling for Chronic Empyema With Bronchopleural Fistula. Cureus, 2025, 17(6): e86964. doi:10.7759/cureus.86964.
[28]	乔名坤, 崔超. 结核性脓胸的外科治疗进展. 继续医学教育, 2022, 36(4): 153-156. doi:10.3969/j.issn.1004-6763.2022.04.039.
[29]	Nakajima Y. Treatment for multidrug-resistant tuberculosis in Japan. Kekkaku, 2002, 77(12): 805-813.
[30]	杨松, 郭建琼, 李同心, 等. 结核病介入诊断与治疗年度进展2023. 中华结核和呼吸杂志, 2024, 47(4): 363-370. doi:10.3760/cma.j.cn112147-20231114-00308.
[31]	曾璞, 牟向东, 王莉洁, 等. 肺毛霉病的支气管镜表现及介入治疗. 中华结核和呼吸杂志, 2023, 46(2):151-157. doi:10.3760/cma.j.cn112147-20220517-00415.
[32]	Shen L, Jiang YH, Dai XY. Successful surgical treatment of bronchopleural fistula caused by severe pulmonary tuberculosis: A case report and review of literature. World J Clin Cases, 2023, 11(10): 2282-2289. doi:10.12998/wjcc.v11.i10.2282. pmid: 37122506
[33]	Lock J, Wiegering A, Germer CT. Indications for surgical treatment of diverticular disease. Chirurg, 2021, 92(8): 694-701. doi:10.1007/s00104-021-01432-7.
[34]	王海, 于冬梅, 顾晔, 等. 支气管单向活瓣在支气管胸膜瘘治疗中的效果及安全性分析. 中华医学杂志, 2022, 102(44): 3520-3524. doi:10.3760/cma.j.cn112137-20220616-01333.
[35]	Xiao Z, Gao J, Zhang H, et al. Application of 3D printing imaging technology in the treatment of bronchopleural fistula with individual customized bronchial occluder. SLAS Technol, 2025: 100344. doi:10.1016/j.slast.2025.100344.
[36]	Lois M, Noppen M. Bronchopleural fistulas: an overview of the problem with special focus on endoscopic management. Chest, 2005, 128(6): 3955-3965. doi:10.1378/chest.128.6.3955. pmid: 16354867

结核性支气管胸膜瘘的诊疗进展

Advances in the diagnosis and treatment of tuberculous bronchopleural fistula

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 36

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李婕, 刘曦, 华伟玉, 张颖. 2015—2024年北京市海淀区肺结核患者诊断延迟影响因素分析[J]. 结核与肺部疾病杂志, 2026, 7(3): 371-376.
[2]	陈芬芬, 邹立巍, 徐舟舟, 赵红. 以肺部感染并发低氧血症为主要表现的惠普尔病一例[J]. 结核与肺部疾病杂志, 2026, 7(3): 404-407.
[3]	李学政. 看懂化验单,结核病治疗更安心[J]. 结核与肺部疾病杂志, 2026, 7(3): 411-412.
[4]	马志明. 结核后肺疾病的研究进展和临床挑战[J]. 结核与肺部疾病杂志, 2026, 7(2): 156-161.
[5]	魏黛珏, 孙建军, 同重湘. GeneXpert MTB/RIF检测在结核性胸膜炎诊断及利福平耐药检测中的应用价值[J]. 结核与肺部疾病杂志, 2026, 7(2): 221-226.
[6]	李凯迪, 樊庆达, 姜文升. 含微乳头成分的IA期肺腺癌研究进展[J]. 结核与肺部疾病杂志, 2026, 7(1): 106-111.
[7]	张嘉诚, 唐神结, 侯代伦, 李亮. 胸部CT联合人工智能辅助检测在肺结核诊疗中的研究进展[J]. 结核与肺部疾病杂志, 2026, 7(1): 112-119.
[8]	江西省胸科医院/江西省卫生健康结核病重点实验室, 广州国家实验室, 中国防痨协会. 结核病宿主来源生物标志物的诊断应用专家共识[J]. 结核与肺部疾病杂志, 2026, 7(1): 9-20.
[9]	张奋军. 微生物快速培养检验法对小儿肺炎支原体感染诊断的价值研究[J]. 结核与肺部疾病杂志, 2025, 6(S1): 8-10.
[10]	姜宇. 血清NT-proBNP、IL-6、PCT、CRP水平联合检测在慢性阻塞性肺疾病并发肺部感染中的诊断效能[J]. 结核与肺部疾病杂志, 2025, 6(S1): 31-32.
[11]	中国中西医结合学会中华中医药学会中华医学会. 耐药肺结核中西医结合诊疗指南[J]. 结核与肺部疾病杂志, 2025, 6(5): 477-494.
[12]	中国防痨协会多学科诊疗分会, 深圳市第三人民医院(国家感染性疾病临床医学研究中心), 首都医科大学附属北京朝阳医院, 广东省肺癌研究所. 肺结核与肺癌共病诊疗专家共识[J]. 结核与肺部疾病杂志, 2025, 6(5): 495-515.
[13]	魏黛珏, 同重湘. 胸腔积液腺苷脱氨酶、全血γ-干扰素和白细胞介素2检测对结核性胸膜炎的诊断价值[J]. 结核与肺部疾病杂志, 2025, 6(5): 525-531.
[14]	王巍松, 韩玮欣, 孟艺哲, 李军霞, 张亚楠. 难治性结核性脑膜炎三例[J]. 结核与肺部疾病杂志, 2025, 6(5): 609-612.
[15]	中国防痨协会结核病控制专业分会, 中国防痨协会标准化专业分会, 中国防痨协会老年结核病防治专业分会. 结核分枝杆菌感染检测技术应用专家共识[J]. 结核与肺部疾病杂志, 2025, 6(4): 365-381.